Results 71 to 80 of about 18,946 (139)

Prognostic Value of Epicardial Adipose Tissue in Heart Failure With Mid‐Range and Preserved Ejection Fraction: A Multicenter Study

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Epicardial adipose tissue (EAT) accumulation is thought to play a role in the pathophysiology of heart failure (HF) with mid‐range ejection fraction and HF with preserved ejection fraction, but its effect on outcome is unknown.
Wenxian Wang   +7 more
doaj   +1 more source

Treatment of Heart Failure with Mid-Range Ejection Fraction: What Is the Evidence. [PDF]

open access: yesJ Clin Med, 2021
Koufou EE   +3 more
europepmc   +1 more source

Heart Failure With Mid-Range (Borderline) Ejection Fraction: Clinical Implications and Future Directions.

open access: yesJACC. Heart failure, 2017
Heart failure (HF) with borderline ejection fraction was first defined in 2013 in the American College of Cardiology/American Heart Association guidelines as the presence of the typical symptoms of HF and a left ventricular ejection fraction (LVEF) of 41% to 49%. In 2016, the European Society of Cardiology specified HF with mid-range ejection fraction (
Hsu, Jeffrey J   +2 more
openaire   +5 more sources

Heart Failure With Mid-Range (Borderline) Ejection Fraction [PDF]

open access: yesJACC: Heart Failure, 2017
Jeffrey J. Hsu   +2 more
openaire   +1 more source

Heart failure with mid‐range ejection fraction: a transition phenotype? [PDF]

open access: yesEuropean Journal of Heart Failure, 2017
Antoni, Bayés-Genís   +2 more
openaire   +2 more sources

Prognostic value of growth differentiation factor‐15 in heart failure among whole ejection fraction phenotypes

open access: yesESC Heart Failure
Aims The utility of growth differentiation factor‐15 (GDF‐15) in predicting long‐term adverse outcomes in heart failure (HF) patients is not well established.
Lyu Lyu   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy